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ABSTRACT
Background: Histiocytic tumors in felines are nodules that commonly develop on limbs and head extremities. They can 
be divided into many subtypes including cutaneous histiocytoma, histiocytic sarcoma, reactive fibrohistiocytic nodule, 
Langerhans cell histiocytosis, and progressive feline dendritic cell. Despite the same origin, they have behaviors that differ 
from each other, thus it is important to confirm diagnosis with histopathological and immunohistochemical tests, because 
early identification can facilitate prognosis and treatment. In this study, we describe the pathological and immunohisto-
chemical characteristics, enabling differentiation feline neoplasms derived from histiocytes. 
Case: A 5-year-old, crossbreed, male, feline presented with a nodulation at the base of the left ear. The mass was slow 
growing, partially alopecic, with no other changes associated with tumor development. The nodule was round and cir-
cumscribed, movable, with an elevated surface. He was referred for surgery and an elliptical sample around the tumor 
was carefully dissected. Routine histopathological evaluation was performed with hematoxylin and eosin (HE), as well 
as immunohistochemistry. Histopathology showed circumscribed proliferation of histiocytic cells, with abundant and 
eosinophilic cytoplasm. The proliferative cells were large and rounded, extending from the superficial dermis and base-
ment membrane to the deep dermis. At the extremities, some cells had visible vacuoles. Mitotic activity ranged from 3 to 
4 mitoses per field in 40x magnification. Immunohistochemistry showed positive staining for histocompatibility complex 
MCII and lysozyme antibodies, marking histiocytic cells. Labeling was positive for CD20 in cells of lymphoid lineage B 
and negative for E-cadherin. Histiocytic cells did not invade the epidermis; hence, proliferation was classified as nonepi-
theliotropic. These methods contribute to the literature regarding the diagnosis of this rare tumor. Therefore, histological 
as well as immunohistochemical evaluation are important bfor confirming clinical diagnosis of histiocytic proliferation 
non-epitheliotropic. 
Discussion: Progressive histiocytosis of feline dendritic cells, in both epitheliotropic and non-epitheliotropic forms, is 
considered a clinically progressive and rare disorder. There are reports which include cytological, clinical, histological and 
immunohistochemical examinations, but the diagnostic characteristics regarding the non-epitheliotropic classification have 
not yet been properly identified. Nodulations are predominantly observed in head and limb regions, usually non-ulcerated, 
which can both increase and decrease in size, and are typically painless. The tumor in the present case was restricted to 
the base of the ear and no evidence of infiltration or metastasis was found. Progressive histiocytosis may spread and reach 
the lymphatic system through the lymph nodes, subsequently becoming systemic. The non-aggressive behavior observed 
in this case is possibly related to the non-epitheliotropic pattern. In the present case, MHC II histocompatibility complex 
markers, a phenotype compatible with dendritic cells, were used. Lysozyme antibodies marked histiocytic cells and the 
reactive lymphoid infiltrate was composed of CD20-positive B lymphoid lineage cells. Staining for E-cadherin was negative, 
negative results in labeling experiments is common, it is dependent upon the cellular origin of the leukocytes present in the 
sample. Staining for these molecules is recommended for differentiating feline progressive histiocytosis from Langerhans 
cells. Langerhans cells can be characterized by E-cadherin expression in about 10% of cases and marked T lymphocyte 
and neutrophil expression in the affected tissue. In this case, the histopathological exam along with immunohistochemistry 
was essential for differentiating them.
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INTRODUCTION
Histiocytic tumors in felines are nodules that 
commonly develop on limbs and head extremities. 
They can be divided into many subtypes including 
cutaneous histiocytoma [2,7], histiocytic sarcoma 
[5], reactive fibrohistiocytic nodule, Langerhans cell 
histiocytosis, and progressive feline dendritic cell 
histiocytosis [1,4,6,8] Despite the same origin, they 
have behaviors that differ from each other, thus it is 
important to confirm diagnosis with histopathological 
and immunohistochemical tests, which can allow vets 
to differentiate between the different types, and early 
identification can facilitate prognosis and treatment [9].
In this study, we describe the pathological and 
immunohistochemical characteristics that can allow 
accurate diagnosis; enabling differentiation between 
non epitheliotropic progressive, histiocytosis of epi-
theliotropic and others feline neoplasms derived from 
histiocytes, such as histiocytomas, as well as common 
skin tumors, mastocytomas, and sarcomas.
CASE
A 5-year-old male, crossbreed, feline presen-
ted with a nodule at the base of the left auricle that 
was characterized by slow and progressive growth. 
Blood count and biochemistry were within the stan-
dards ranges considered normal for this species. The 
neoplasm of the ear region was circumscribed, and 
1 cm in diameter and could be further described as a 
single, nodular, unattached, non-ulcerated, gelatinous 
mass, which was limited to the dermis layer (Figure 1). 
When an incision was made, the interior was soft and 
greasy in consistency. He was referred for histological 
processing performed with HE1.
Microscopy showed a dense, unencapsulated 
mass with circumscribed proliferation of histiocytic 
cells, which had abundant and eosinophilic cytoplasm 
(Figure 2A). The proliferative cells were enlarged and 
rounded, with centrally located nuclei ranging from round 
to oval in shape. These cells had broad cytoplasms, but 
sometimes in regions near the center of the nodule, the 
cytoplasm was scarce and with poorly defined edges. 
The cells infiltrated the tissues to the superficial dermis, 
and some cells, which had vacuoles were located at the 
extremities of the lesion. Some of these invading cells 
were associated with an inflammatory infiltrate consisting 
of lymphoplasmacytoid cells which intermingled with the 
neoplastic cells and limited cell proliferation (Figure 2B).
The neoplasm developed at the basement mem-
brane without invasion of the underlying epidermis. 
Mitotic activity ranged from 3 to 4 mitoses per field 
in 40x magnification. CD202, E-cadherin2, MHCII2 
(Figure 2C), and lysozyme2 (Figure 2D), antibodies 
were used for immunohistochemistry analysis.
DISCUSSION
The diagnosis of feline progressive his-
tiocytosis in the present case was determined by his-
topathological and immunohistochemical evaluation. 
The histological type of the tumor was confirmed by 
observing that a proliferative lesion with a diffuse 
infiltration pattern of histiocytes, which did not reach 
the underlying dermis, was characteristic of the none-
pitheliotropic type [6].
Progressive histiocytosis of feline dendritic 
cells, in both epitheliotropic and non-epitheliotropic 
forms, is considered a clinically progressive and rare 
disorder. There are reports which include cytological, 
clinical, histological and immunohistochemical exa-
minations, but the diagnostic characteristics regarding 
the non-epitheliotropic classification have not yet 
Figure 1. Progressive histiocytosis of non-epitheliotropic feline dendritic 
cells (HPD). Macroscopy of nodule at the base of the feline ear. Partly 
alopecic, rounded, and circumscribed.
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been properly identified [1]. Nodulations are predo-
minantly observed in head and limb regions, usually 
non-ulcerated, which can both increase and decrease 
in size, and are typically painless [6,9,11]. There is 
no predisposition regarding age or breed, but a study 
involving 30 cases points to a greater predisposition 
among females [1].
The tumor in the present case was restricted 
to the base of the ear and no evidence of infiltration 
or metastasis was found. According to literature, pro-
gressive histiocytosis may spread and reach the lym-
phatic system through the lymph nodes, subsequently 
becoming systemic. When systemic, multiple nodules 
extend from the initial nodule and may become ulce-
rated and plaque-shaped [6-8,10]. The non-aggressive 
behavior observed in this case is possibly related to the 
non-epitheliotropic pattern.
In this study, the histological characteristics 
and immunohistochemistry both suggested the same 
diagnosis and were distinctly different to the charac-
teristics typically seen in progressive histiocytosis 
types. In the microscopic examination, it was possible 
to observe that the tumor was restricted to the dermis 
layer, differing from the epitheliotropic type that often 
adhered to reaches epidermis and subcutaneous, but 
macroscopy could also become ulcerated and even 
form multiple masses or multinodular masses as the 
disease progressed [8].
This type of tumor is clinically indistinguisha-
ble from other neoplastic, allergic and inflammatory 
diseases, such as granulomas and tumor metastases 
[10], as well as other primary neoplasms, xanthomas, 
sarcomas and mastocytomas [5,6].  These conditions 
are important differentials within the histological 
examination and should be addressed initially by mor-
phology and when possible, through specific markers 
in immunohistochemistry, as they commonly change 
over time [9].
For tumors of histiocytic origin antibodies 
should be applied, such as CD18, CD1, MHC II 
(major histocompatibility complex) that mark cells 
of histiocytic origin, while lysozyme antibodies can 
Figure 2. A- HPD microscopy showing circumscribed round cell proliferation, infiltration of randomly distributed plasma cells and lymphocytes, some-
times forming cords [HE; Magnification: 20x]. B- The histiocytes had proliferative and eosinophilic cytoplasm, proliferative, enlarged and rounded, with 
nucleus ranging from round to oval, centrally located [HE; Magnification: 40x]. C- HLA-DR antibody, highlighting cells of histiocytic origin densely 
labeled by the MHCII Histocompatibility complex. D- Intense brown marking of cells of histiocytic origin by the lysozyme antibody. 
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mark myeloid granulocytes and histiocytes [3,6]. In 
the present case, MHC II2 histocompatibility complex 
markers, a phenotype compatible with dendritic cells, 
were used. Lysozyme2 antibodies marked histiocytic 
cells and the reactive lymphoid infiltrate was composed 
of CD202-positive B lymphoid lineage cells. Staining 
for E-cadherin2 was negative, negative results in la-
beling experiments is common, it is dependent upon 
the cellular origin of the leukocytes present in the 
sample. Staining for these molecules is recommended 
for differentiating feline progressive histiocytosis from 
Langerhans cells [4].
Langerhans cells can be characterized by 
E-cadherin expression in about 10% of cases and 
marked T lymphocyte and neutrophil expression in 
the affected tissue. Approximately 30% of cases are 
cutaneous, while 10% of diagnosed cases are systemic. 
Importantly, the tumor can be successfully treated by 
corticosteroid, cyclosporine, and leflunomide-based 
medicines [6,11]. In this case, the histopathological 
exam along with immunohistochemistry was essential 
for differentiating them.
Improvements to the diagnosis of rare tumors 
are required. This study demonstrated the utility of 
various diagnostic methods, including clinical and 
histological characterization as well as immunohis-
tochemical analysis, to confirm tentative diagnosis. 
Based on this report, it is possible to assist clinicians 
and pathologists regarding the diagnostic conduct.
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